Chonnam Med J.  2019 Jan;55(1):68-69. 10.4068/cmj.2019.55.1.68.

Clinical Significance of the Interval Change of Plasma Neutrophil Gelatinase-Associated Lipocalin in Acute Kidney Injury and Acute Kidney Injury Superimposed on Chronic Kidney Disease

• Kim HY
• Kim CS
• Bae EH
• Kim SW
• Ma SK

• KMID: 2432261
• DOI: http://doi.org/10.4068/cmj.2019.55.1.68

Abstract

No abstract available.

MeSH Terms

Acute Kidney Injury*
Lipocalins*
Neutrophils*
Plasma*
Renal Insufficiency, Chronic*
Lipocalins

Reference

1. Hsu CY, Ordoñez JD, Chertow GM, Fan D, McCulloch CE, Go AS. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int. 2008; 74:101–107.

2. Stevens LA, Levey AS. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol. 2009; 20:2305–2313.

3. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A. NGAL Meta-analysis Investigator Group. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009; 54:1012–1024.

4. Doi K, Urata M, Katagiri D, Inamori M, Murata S, Hisagi M, et al. Plasma neutrophil gelatinase-associated lipocalin in acute kidney injury superimposed on chronic kidney disease after cardiac surgery: a multicenter prospective study. Crit Care. 2013; 17:R270.